Targeting hypoxic cells through the DNA damage response

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• Hypoxia is prevalent in solid tumors, influencing tumor progression and treatment resistance.
• Tumor reoxygenation, a dynamic process, further complicates cellular responses to hypoxia.
• Understanding the DNA damage response (DDR) under hypoxia is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the DNA damage response (DDR) initiated by hypoxia-induced replication arrest.
• To elucidate the distinct mechanisms of hypoxia-induced DDR compared to classical DNA damaging agents.
• To identify potential therapeutic targets within the hypoxia-induced DDR pathways.

Main Methods:

• DNA fiber analysis to assess replication fork dynamics.
• Evaluation of nucleotide levels during hypoxic conditions.
• Assessment of DNA damage response signaling pathways, including ATR, ATM, and p53.
• Analysis of the impact of hypoxia and reoxygenation on DNA repair components.

Main Results:

• Hypoxia-induced replication arrest affects both initiation and elongation, correlating with decreased nucleotide pools.
• The hypoxia-induced DDR is characterized by a lack of detectable DNA damage and repressed DNA repair.
• Key DDR components like ATR, ATM, Chk1, and PARP are critical for survival under hypoxia/reoxygenation.
• Phosphorylation of H2AX in endothelial cells under moderate hypoxia suggests a role in proliferation and angiogenesis.

Conclusions:

• The hypoxia-induced DDR aims to induce apoptosis or preserve replication fork integrity for potential reoxygenation.
• Hypoxic and reoxygenating tumor cells are sensitive to the inhibition of specific DDR components.
• Targeting hypoxia-induced p53 signaling or H2AX phosphorylation presents promising therapeutic avenues for hypoxic tumors.